These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24445310)

  • 1. Design, synthesis, biological evaluation, and comparative docking study of 1,2,4-triazolones as CB1 receptor selective antagonists.
    Han S; Zhang FF; Xie X; Chen JZ
    Eur J Med Chem; 2014 Mar; 74():73-84. PubMed ID: 24445310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
    J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,3-Triazole derivatives as new cannabinoid CB1 receptor antagonists.
    Hou DR; Alam S; Kuan TC; Ramanathan M; Lin TP; Hung MS
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1022-5. PubMed ID: 19095444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.
    Boström J; Berggren K; Elebring T; Greasley PJ; Wilstermann M
    Bioorg Med Chem; 2007 Jun; 15(12):4077-84. PubMed ID: 17433696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology models of the cannabinoid CB1 and CB2 receptors. A docking analysis study.
    Montero C; Campillo NE; Goya P; Páez JA
    Eur J Med Chem; 2005 Jan; 40(1):75-83. PubMed ID: 15642412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use.
    Chang CE; Ai R; Gutierrez M; Marsella MJ
    Methods Mol Biol; 2012; 819():595-613. PubMed ID: 22183560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
    Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of cannabinoid-1 receptor antagonists by virtual screening.
    Lee GN; Kim KR; Ahn SH; Bae MA; Kang NS
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5130-2. PubMed ID: 20667724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
    Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
    J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
    Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
    Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model.
    Wang H; Duffy RA; Boykow GC; Chackalamannil S; Madison VS
    J Med Chem; 2008 Apr; 51(8):2439-46. PubMed ID: 18363352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.
    Lange JH; van Stuivenberg HH; Veerman W; Wals HC; Stork B; Coolen HK; McCreary AC; Adolfs TJ; Kruse CG
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4794-8. PubMed ID: 16140010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a 3D model for the human cannabinoid CB1 receptor.
    Salo OM; Lahtela-Kakkonen M; Gynther J; Järvinen T; Poso A
    J Med Chem; 2004 Jun; 47(12):3048-57. PubMed ID: 15163186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
    Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
    J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.
    Kuang G; Hu G; Sun X; Li W; Liu G; Tang Y
    J Mol Model; 2012 Aug; 18(8):3831-45. PubMed ID: 22402754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.
    Cichero E; Ligresti A; Allarà M; di Marzo V; Lazzati Z; D'Ursi P; Marabotti A; Milanesi L; Spallarossa A; Ranise A; Fossa P
    Eur J Med Chem; 2011 Sep; 46(9):4489-505. PubMed ID: 21835510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights.
    Scrima M; Di Marino S; Grimaldi M; Mastrogiacomo A; Novellino E; Bifulco M; D'Ursi AM
    Biochemistry; 2010 Dec; 49(49):10449-57. PubMed ID: 21062041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.